Navigation Links
Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18

ed antibody response to active immunization (see PRECAUTIONS, Drug Interactions). As with other intramuscular injections, GARDASIL should not be given to individuals with bleeding disorders such as hemophilia or thrombocytopenia, or to persons on anticoagulant therapy unless the potential benefits clearly outweigh the risk of administration. If the decision is made to administer GARDASIL to such persons, it should be given with steps to avoid the risk of hematoma following the injection. Information for the Patient, Parent, or Guardian The health care provider should inform the patient, parent, or guardian that vaccination does not substitute for routine cervical cancer screening. Women who receive GARDASIL should continue to undergo cervical cancer screening per standard of care. The health care provider should provide the vaccine information required to be given with each vaccination to the patient, parent, or guardian. The health care provider should inform the patient, parent, or guardian of the benefits and risks associated with vaccination. For risks associated with vaccination, see PRECAUTIONS and ADVERSE REACTIONS. GARDASIL is not recommended for use in pregnant women. The health care provider should inform the patient, parent, or guardian of the importance of completing the immunization series unless contraindicated. Patients, parents, or guardians should be instructed to report any adverse reactions to their health care provider. Drug Interactions Use with Other Vaccines Results from clinical studies indicate that GARDASIL may be administered concomitantly (at a separate injection site) with hepatitis B vaccine (recombinant) (see CLINICAL PHARMACOLOGY, Studies with Other Vaccines). Co-administration of GARDASIL with other vaccines has not been studied. Use with Hormonal Contraceptives In clinical studies, 13,293 subjects (vaccine = 6644; placebo = 6649) who had post-Month 7 foll
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32

Related medicine technology :

1. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
2. New Proof of Genisteins Efficacy and Safety for Osteopenia and Osteoporosis Published in Annals of Internal Medicine
3. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
4. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
5. VIVUS Announces Abstract Published at American Diabetes Association Scientific Sessions
6. Anacor Identifies a Novel Mechanism for Its Lead Anti-Fungal Drug, AN2690; Findings Published in Science
7. Research on New Treatment for Neglected Disease Published in The New England Journal of Medicine
8. Landmark Study Published in the New England Journal of Medicine Shows Important Benefits of Eprodisate (KIACTA) Treatment for Patients with Amyloid A (AA) Amyloidosis
9. Newly Published Data from Large Study Support Cardiovascular Safety of Avandia (Rosiglitazone Maleate)
10. Javelin Pharmaceuticals Phase II Rylomine (Intranasal Morphine) Data Published in Pain Medicine
11. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression
Post Your Comments:
(Date:2/27/2015)... N.C. , Feb. 27, 2015 Pharmaceutical ... of managing multiple products for the same indication. This ... those that want to prevent one of their brands ... According to recent research by benchmarking firm, ... products as independent brands rather than together as part ...
(Date:2/27/2015)... , Feb. 27, 2015  Acsis Inc., the market ... solutions, announced today that John DiPalo , Acsis, ... Supply & Demand Chain Executive 2015 Provider Pro ... are leading initiatives to help prepare their companies, and ... business climate. This year,s list of Provider Pros to ...
(Date:2/27/2015)... HOUSTON, TX , Feb. 27, 2015 /PRNewswire/ ... and Bloom Burton & Co. Ltd. ("Bloom Burton") today ... (the "Lock-Up") 2,353,130 common shares of the Company ("Common ... to the Lock-Up. Of the Common Shares released from ... upon release from the Lock-Up while the remainder will ...
Breaking Medicine Technology:New Report Details How to Expand a Pharmaceutical Product Portfolio without Cannibalizing an Established Brand 2Acsis CSO John DiPalo Named Supply & Demand Chain Executive 2015 Pro to Know 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 3ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 4
... CITY, Calif., Feb. 8, 2012 Cardica, Inc. (Nasdaq: ... public offering of 9,091,000 shares of its common stock, offered ... The gross proceeds to Cardica from this offering are expected ... and other estimated offering expenses payable by Cardica.  The offering ...
... (NASDAQ: MLAB ) today reported a 21 percent increase in ... fiscal third quarter ended December 31, 2011. Highlights: ... to $1,987 ,000 Quarterly revenues increased 21% year over ... sales growth in the fiscal third quarter Quarterly non-GAAP ...
Cached Medicine Technology:Cardica Prices Public Offering of Common Stock 2Mesa Labs Reports 58 Percent Increase in Third Quarter Net Income 2Mesa Labs Reports 58 Percent Increase in Third Quarter Net Income 3Mesa Labs Reports 58 Percent Increase in Third Quarter Net Income 4Mesa Labs Reports 58 Percent Increase in Third Quarter Net Income 5
(Date:3/2/2015)... Final Cut Pro X plugin specialists ... Pixel Film Studios. , “The TranStatic Volume 2 plugin gives ... Austin, CEO of Pixel Film Studios. “TranStatic Volume 2 is ... X editors toolbox.” , With TranStatic Volume 2 users can ... static scrambling effects from Pixel Film Studios. Users have total ...
(Date:3/1/2015)... Women’s Excellence is pleased to announce the addition of ... There are over 75 terms and phrases available for viewing, ... gives our patients a better understanding of what our Providers are ... understand. With this resource, our patients are able to go ... and phrases that they may not remember or comprehend at the ...
(Date:3/1/2015)... 2015 A federal court overseeing ... scheduled to go to trial in October has ... to provide testimony regarding the role an Italian ... Profemur device, Bernstein Liebhard LLP comments. According to ... District of Iowa on February 25th, Wright Medical ...
(Date:3/1/2015)... 01, 2015 “ The Barrel Mill ” ... Report, which takes a look at the latest and coolest ... host of NewsWatch and a technology expert, conducted the review ... flavor to drinks. , According to Home Distillation of Alcohol, ... spirits. Well, there’s a pretty cool product that’ll help anyone ...
(Date:2/28/2015)... Dallas, TX (PRWEB) March 01, 2015 ... is estimated that 10 percent of urban adult population ... some form of heart diseases and 20-30 percent of ... due to heart ailments and coronary vascular diseases (CVD). ... has launched a new market research report titled “Indian ...
Breaking Medicine News(10 mins):Health News:Pixel Film Studios released the TranStatic Volume 2 plugin for Final Cut Pro X today 2Health News:Wright Profemur Hip Lawyers at Bernstein Liebhard LLP Comment on Court’s Decision Regarding Testimony Pertaining to Prototype for Profemur Hip Replacement 2Health News:Wright Profemur Hip Lawyers at Bernstein Liebhard LLP Comment on Court’s Decision Regarding Testimony Pertaining to Prototype for Profemur Hip Replacement 3Health News:An Oak Infusion Spiral was Featured on NewsWatch Television on January 30, 2015 2Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 2Health News:India Coronary Stent Market 2019 Forecasts Analysis in New Research Report Available at MarketReportsOnline.com 3
... experience a change in health caused by an unintentional injury ... to have difficulty// obtaining recommended medical care and more likely ... study. ,Jack Hadley, Ph.D., of the Urban Institute, ... a JAMA media briefing on access to care at the ...
... research published in the P Los (Public Library of Science) ... it comes to speculating// the wishes of a terminally sick ... stumbled upon this finding while he was analyzing the decisions ... of action involving a critically ill patient. ,Wendler ...
... studies has revealed that autism is far more complex than ... the National Institute for Mental Health// , seems to suggest ... 100 different genes. ,It turns out many ... certainly complicates the search for the specific genes contributing to ...
... must amend its new aged care legislation to protect vulnerable// ... ,The proposed Aged Care Amendment (Security and Protection) Bill ... calls for the compulsory reporting of any physical and sexual ... Report of the Senate Committee on Community Affairs inquiry into ...
... the recent oncology survey conducted in British Columbia, the cancer ... survey was conducted among 7000 cancer patients by the ministry ... been appreciated by 97.1% of the people and more than ... not made to wait for a longer time for radiation ...
... good news for a change, from the Centers for Disease ... officials, hepatitis statistics have decreased significantly in their count, over ... to routine hepatitis immunizations, in children. , The ... hepatitis viruses in 2005, compared to about 500,000 in 1995. ...
Cached Medicine News:Health News:Uninsured Often Receive Less Medical Care 2Health News:AMA Urges Government To Amend Aged Care Legislation 2Health News:Hepatitis Rates Plummet in the U.S 2
... Eppendorf has created this extremely versatile ... in laboratory liquid handling. With EDOS, high ... are completed with ease. ,The smallest ... of the corresponding Combitip. The easy-to-follow user ...
The WellPro 384 is designed for use with 384 well microplates. It utilizes a 24 channel liquid head and can perform serial dilutions in a 16 or 24 across format, and plate to plate transfers and plat...
Wellpro 96 an automated liquid handling system for 96-well plates that quickly and accurately prepares large quantities of serial dilutions. The Wellpro also performs plate to plate transfers using ...
... workstations is designed for laboratories with limited ... automation platform for routine sample preparation and ... throughput, process consistency and safety. Windows ... you to control the robotic and liquid ...
Medicine Products: